Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease. Cusick MF, Libbey JE, Trede NS, Fujinami RS PLoS One. 2014; 9(4):e94486. Epub 2014 Apr 09. PMID: 24718491. Abstract CommentRecommendBookmarkWatch